Found 31 news articles for Ovarian cancer

Order by most

Recent Relevant

  • COVID can’t stop cancer pioneer finishing his Ride4Research

    Not even COVID-19 could stop a pioneer in the fight against rare ovarian cancers finishing his epic fundraising Ride4Research ride. Eight-year-old Neve presents fundraising cheque to riders finishing Ride4Research. In……  Read more

    Eight-year-old Neve presents fundraising cheque to riders finishing Ride4Research.

  • Firefighters Charity Fund supports BRCA1 research

    Associate Professor Michael Gantieir and PhD researcher Alexandra McAllan with the group from Fire Rescue Victoria with novelty cheque representing their donation. On 16 March we were delighted to welcome……  Read more

    Firefighters Charity Fund support BRCA1 gene sequencing at Hudson Institute of Medical Research.

  • Cancer pioneer Simon Chu’s Ride4Research

    Dr Simon Chu takes part in Ride4Research with a crew of dedicated supporters and cyclists, making the trek from Canberra to Melbourne, raising vital funds and awareness for ovarian cancer….…  Read more

    Dr Simon Chu in the fight against rare ovarian cancers and takes a break from the lab and putting rubber on the road as part of the Ride4Research.

  • Shining light on juvenile ovarian cancer

    Seeing their baby diagnosed with a rare ovarian cancer (ROC) before her first birthday instantly made one Central Victorian family advocates for medical research. The day of Neve’s ROC surgery……  Read more

    8-year-old Neve, who was treated for a juvenile granulosa cell tumour at 11-months old

  • Funding boost for ovarian cancer research

    Hudson Institute of Medical Research is proud to be a recipient in the latest round of funding from the Ovarian Cancer Research Foundation (OCRF). Professor Ron Firestein Professor Ron Firestein,……  Read more

    Professor Ron Firestein from the Cancer Genetics and Functional Genomics Research Group at Hudson Institute

  • Ovarian cancer treatment hope

    Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most……  Read more

    Scientist, Dr Amy Wilson at Hudson Institute

  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million. Ideas Grants fund innovative and creative……  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients

  • $2.2 million awarded to tackle rare ovarian cancer

    Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods. Dr Simon Chu Led……  Read more

    Professor Peter Fuller AM and Dr Simon at the Hudson Institute of Medical Research

  • Simple blood test can improve ovarian cancer diagnosis

    Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer. Ovarian cancer is one of the most common gynaecologic cancers,……  Read more

    Dr Andrew Stephens from the Ovarian Cancer Biomarkers Research Group at Hudson Institute

  • Congratulations to our CASS Foundation grant awardees

    Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary……  Read more

    2020 Successful CASS Foundation Grants applicants